✦ LIBER ✦

Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer

✍ Scribed by G. Thomas Budd; Pamela Herzog; Ronald M. Bukowski

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 327 KB
Volume: 12
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly mitoxantrone, 5

Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer

✍ Lazzaro Repetto; Loredana Miglietta; Giovanni Gardin; Claudio Lanfranco; Cinzia 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 426 KB

A phase II trial of tamoxifen, premarin,

A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer

✍ Joseph C. Allegra; Thomas M. Woodcock; Stephen P. Richman; Kirby I. Bland; James 📂 Article 📅 1982 🏛 Springer US 🌐 English ⚖ 773 KB

A phase III randomized trial of cyclopho

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

✍ M. C. Alonso; J. M. Tabernero; B. Ojeda; M. Llanos; C. Solà; M. A. Climent; M. A 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 788 KB

A phase II trial of continuous infusion

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma

✍ Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Yoriko Takezako; Chigusa Morizane 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Phase II trial of carboplatin and etopos

Phase II trial of carboplatin and etoposide in metastatic breast cancer

✍ John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg

Phase II trial of doxorubicin and triflu

Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer

✍ G. T. Budd; R. M. Bukowski; A. Lichtin; L. Bauer; P. Kirk; R. Ganapathi 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 361 KB